Agoracom: Small Cap Investment - Resverlogix Corp. - Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

Jul 25, 2021 02:32PM

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

EggBeater66

Jul 25, 2021 03:29PM

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

KOO-KOO2

Jul 25, 2021 03:30PM

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

sidebar

Jul 27, 2021 12:42AM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

in response to

Re: From today's WSJ...Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, Merck Shionogi starts human trials

sidebar

posted on Jul 28, 2021 07:47AM

"does it seem strange that Pfizer has developed a near similar drug to ABL or has it? thought we had a patent."

Pfizer is developing an oral COVID-19 protease inhibitor that has already completed Phase 1 trial, is expected to start Phase 2/3 any day, with potential US EUA submission in Q4 2021. Resverlogix is developing an oral BET inhibitor that has shown promising pre-clinical effects for SARS-CoV2/COVID-19 but has yet to start any human clinical trial. Apples and oranges. No patent issue.

Update on Pfizer's drug: https://twitter.com/megtirrell/status/1420342459368882183?s=20